Zobrazeno 1 - 10
of 571
pro vyhledávání: '"Quinn Smith"'
Autor:
Krol, Jacklyn
Publikováno v:
People.com; 8/18/2024, pN.PAG-N.PAG, 1p
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionThe aim of this study is to conduct a meta-analysis to assess the efficacy of yttrium-90 selective internal radiation therapy (SIRT) in treating patients with breast cancer with hepatic metastasis.MethodPubMed and The Cochrane Library wer
Externí odkaz:
https://doaj.org/article/81e815734971442d81d4c18cf416ba1e
Autor:
Chenyu Liu, Matthew Wolfers, Bint‐e Zainab Awan, Issa Ali, Adrian Michael Lorenzana, Quinn Smith, George Tadros, Qian Yu
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 23 (2021)
Background Both drug‐coated balloon (DCB) angioplasty and conventional plain balloon angioplasty (PBA) can be implemented to treat hemodialysis dysfunction. The present study aims to compare the safety and efficacy of these 2 approaches by conducti
Externí odkaz:
https://doaj.org/article/5d608e001dff4bfdafa86486d1554178
Autor:
NORDSTROM, LEIGH
Publikováno v:
WWD: Women's Wear Daily. 5/19/2021, p23-23. 1p.
Autor:
Shannon E. Elf, Scott A. Oakes, Rebekka K. Schneider, Sandeep Gurbuxani, Steffen Koschmieder, Silvia Catricala, Ilaria Carola Casetti, Daniela Pietra, Elisa Rumi, Jonathan Dowgielewicz, Luke Maxwell, Diane Silva, Benjamin Nicholson, Kathrin Olschok, Milena Kalmer, Julian Baumeister, Julian Lutze, Quinn Smith, Chenyu Liu, Althea Bock-Hughes, Maria Evers, Deborah Rodriguez, Nicole S. Arellano, Harrison S. Greenbaum, Michele Ciboddo, Katarzyna Kurylowicz, Yassmin A. Elbanna, Juan Ibarra
Supplementary Data from Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d504c47564df319c5c1e8f5b6b7e98a
https://doi.org/10.1158/2643-3230.22545003
https://doi.org/10.1158/2643-3230.22545003
Autor:
Shannon E. Elf, Scott A. Oakes, Rebekka K. Schneider, Sandeep Gurbuxani, Steffen Koschmieder, Silvia Catricala, Ilaria Carola Casetti, Daniela Pietra, Elisa Rumi, Jonathan Dowgielewicz, Luke Maxwell, Diane Silva, Benjamin Nicholson, Kathrin Olschok, Milena Kalmer, Julian Baumeister, Julian Lutze, Quinn Smith, Chenyu Liu, Althea Bock-Hughes, Maria Evers, Deborah Rodriguez, Nicole S. Arellano, Harrison S. Greenbaum, Michele Ciboddo, Katarzyna Kurylowicz, Yassmin A. Elbanna, Juan Ibarra
Approximately 20% of patients with myeloproliferative neoplasms (MPN) harbor mutations in the gene calreticulin (CALR), with 80% of those mutations classified as either type I or type II. While type II CALR-mutant proteins retain many of the Ca2+ bin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::016efe4195fef443d3f9880b5f0730f8
https://doi.org/10.1158/2643-3230.c.6550824
https://doi.org/10.1158/2643-3230.c.6550824
Autor:
Juneau, Jen
Publikováno v:
People.com; 10/5/2024, pN.PAG-N.PAG, 1p
Autor:
Juan Ibarra, Yassmin Elbanna, Katarzyna Kurylowicz, Michele Ciboddo, Harrison S. Greenbaum, Nicole S. Arellano, Deborah Rodriguez, Maria Evers, Dongbo Yang, Althea Bock-Hughes, Chenyu Liu, Quinn Smith, Julian Baumeister, Milena Kalmer, Kathrin Olschok, Benjamin Nicholson, Diane Silva, Jonathan Dowgielewicz3, Elisa Rumi, Daniela Pietra, Ilaria Carola Casetti, Steffen Koschmieder5, Sandeep Gurbuxani, Rebekka K. Schneider, Scott A. Oakes, Shannon E. Elf
Publikováno v:
Cancer Research. 82:LB134-LB134
Approximately 20% of patients with myeloproliferative neoplasms (MPN) harbor mutations in the gene calreticulin (CALR). 80% of CALR mutations are classified as either type 1 or type 2, exemplified by a 52 bp deletion (CALRdel52) and a 5 bp insertion
Autor:
Matthew Wolfers, Quinn Smith, George Tadros, Bint-E Zainab Awan, Adrian Michael Lorenzana, Qian Yu, Chenyu Liu, Issa Ali
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 23 (2021)
Background Both drug‐coated balloon (DCB) angioplasty and conventional plain balloon angioplasty (PBA) can be implemented to treat hemodialysis dysfunction. The present study aims to compare the safety and efficacy of these 2 approaches by conducti
Publikováno v:
Athletics; Jul2009, p4-5, 2p